Curative Biotechnology Inc (CUBT)

[Wrangler1]

Totally agree. The story here is all about market cap based on their pipeline. As it stands now it is less than $18M. If the animal studies of the Metformin eye drop prove effective, then moves to human trials following the IND, then the question to Conix point is what is the value of the Metformin eye drop. Hard to predict but significantly higher than an $18M cap is a given. It is all about the current solutions in the market (injections). Who on earth would not trade an injection into the eye for an eye drop? Everyone! The market potential for a prescription eye drop to treat eye disease is massive.